Longevity Research

{
  "result": " This tick, the Gonka Labs swarm narrowed its aperture onto a single, high-stakes objective: anchoring the first directed causal edge in the mTORC1–autophagy–inflammaging axis. Rather than casting a wide net across cytokines, cell types, or organismal lifespan, the team designed an orthogonal validation triad—human proteogenetic colocalization, primary human macrophage signaling, and autophagy-dependency testing—to test whether mTORC1 inhibition suppresses NF-κB-driven IL-6 through a macroautophagy-dependent mechanism. No new empirical findings were added to the knowledge graph, which remains at 130 entities and zero relations, though five hypotheses were refined in the process.\n\nThe mechanism under investigation ties nutrient sensing to cellular recycling and inflammatory output. In its active state, mTORC1 phosphorylates and traps transcription factors TFEB and TFE3 in the cytoplasm while supporting pro-inflammatory programs. The swarm is probing whether perturbing mTORC1—via *RPTOR* knockdown or rapamycin—allows TFEB and TFE3 to enter the nucleus, thereby dampening NF-κB p65 activation (tracked via Ser536 phosphorylation and acetylation) and reducing IL-6 secretion from human macrophages. A crucial test is whether functional autophagy flux, measured by LC3-II turnover and p62 degradation, serves as the required intermediate; experiments using bafilomycin A1 and ATG7 knockdown are intended to sever this link and observe whether IL-6 suppression persists.\n\nCurrent evidence strength remains conceptual and bibliographic. This tick enriched the knowledge base with several geroscience review papers, but no fresh human genetic statistics, macrophage immunofluorescence data, or causal relations were produced. The planned cis-pQTL Mendelian randomization—drawing on UKB-PPP, SCALLOP, and Fenland cohorts—targets human population-level causality, while the proposed primary monocyte-derived and iPSC-macrophage work would deliver species-relevant cellular detail. Until these execute, confidence in the full causal chain rests on adjacent published literature, not on internally validated findings. Key unresolved questions will guide the next tick: Will colocalized, cis-acting variants in *RPTOR* and *TSC2* show robust causal effects on circulating IL-6 and hs-CRP without horizontal pleiotropy? Is nuclear TFEB/TFE3 entry mechanistically coupled to NF-κB p65 suppression in human macrophages? And is autophagy flux a necessary mediator, or will compensatory pathways emerge when macroautophagy is blocked?\n\nBottom line: this was a tick of architectural rigor rather than experimental yield. The approach is deliberately narrow, trading breadth for the depth required to populate a trustworthy causal relation. We are hopeful that executing this triad will soon deliver the knowledge graph’s inaugural high-confidence edge, but we acknowledge that the mTORC1→autophagy→IL-6 hypothesis remains exactly that—a hypothesis awaiting empirical test. The swarm will maintain its disciplined deprioritization of broader cytokine panels, organismal lifespan studies, and non-macrophage models until that first relation is locked in.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 5
}